NIPH (WHO CC)
The WHO Collaborating Centre for Drug Statistics Methodology Centre is located in Oslo at the Norwegian Institute of Public Health and funded by the Norwegian government. In collaboration with WHO, the Centre develops and maintains the ATC/DDD methodology. The purpose of the methodology is to serve as a tool for drug utilization monitoring and research […]
EDQM
The European Directorate for the Quality of Medicines & HealthCare (EDQM) is a directorate of the Council of Europe which has the vision of creating a common European Pharmacopoeia. This pharmacopeai is an official reference work used by professionals involved in the manufacture and control of medicines. Its objective is to define legally binding quality […]
UPPSALA Monitoring Centre (WHO CC)
Uppsala Monitoring Centre (UMC) UMC was established in Uppsala, Sweden in 1978 as the World Health Organization (WHO) Collaborating Centre for International Drug Monitoring. UMC operates the technical and scientific aspects of the WHO’s worldwide pharmacovigilance network. Iys main tasks are: providing independent and high-quality medical reference sources globally, exploring the risks and benefits of […]
MedDRA
The development of MedDRA was started in the late 1990s by the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH). MedDRA is a rich and highly specific standardised medical terminology to facilitate sharing of regulatory information internationally for medical products used by humans. MedDRA is made available by ICH to […]
European Committee for Standardisation
CEN TC 251 delivers and maintains health informatics standards for Europe, preferably by producing them in co-operation with other SDOs at a global level and by adopting standards from other SDOs. CEN TC 251 will seek to further increase engagement with other standards development organisations, consortia and fora to enhance efforts to coordinate its work […]
GS1 Healthcare
GS1 Healthcare is a neutral and open community bringing together all related healthcare stakeholders to lead the successful development and implementation of global GS1 standards, enhancing patient safety, and operational and supply chain efficiencies. The development and implementation of GS1 standards is led by the experts who use them: pharmaceutical and medical device manufacturers, wholesalers, […]
